Analyst firms · Raymond James · ALLO
Raymond James ALLO price target and rating history
Allogene Therapeutics Inc. (ALLO) · Health Care
Raymond James rates Allogene Therapeutics Inc. (ALLO) Mkt Perform with a $36 price target, as of its latest action on Aug 10, 2022. It has published 4 rating actions on ALLO since September 2021, including 3 upgrades and 1 downgrade.
- Current rating
- Mkt Perform
- Price target
- $36
- Median target, all firms
- Too few
- Actions on ALLO
- 4
Raymond James price target on ALLO
Every Raymond James rating on ALLO
- Aug 10, 2022
- Sep 24, 2021
- Sep 23, 2021
- Sep 23, 2021
How other firms rate ALLO
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Jefferies | Buy | $6 | Apr 10, 2026 |
| Citizens JMP | Mkt Outperform | $5 | Jan 9, 2026 |
Questions about Raymond James and ALLO
- What is Raymond James's price target for ALLO?
- Raymond James's latest stated price target for Allogene Therapeutics Inc. (ALLO) is $36, from its action on Sep 24, 2021.
- What is Raymond James's rating on ALLO?
- Raymond James rates ALLO Mkt Perform, a neutral rating, as of Aug 10, 2022.
- When did Raymond James last change its view on ALLO?
- On Aug 10, 2022, Raymond James downgrades to Mkt Perform from Outperform.
More ALLO rating histories
All Raymond James ratingsALLO news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.